Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, Hunan Warner Pharmaceutical Co., Ltd. (“Chiral Drugs”), a wholly-owned subsidiary of the company, received terbutaline sulfate's “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2026YS00963) issued by the State Drug Administration and publicized it on the “Original and Auxiliary Package Registration Information” platform of the China Drug Administration (CDE).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.